openPR Logo
Press release

Beta-Lactam Drugs Market 2020 Report on Study of Annual and Financial Condition of Top Players (GSK, Pfizer, Merck, AstraZeneca) by Growth till 2024

04-21-2020 06:17 AM CET | Health & Medicine

Press release from: Business Industry Reports

Beta-Lactam Drugs

Beta-Lactam Drugs

The report on Global Beta-Lactam Drugs Market 2020 includes a study of annual and financial reports of top players, Market Share and Market Size. This research report offers in-depth study of Key Players, Product and Regional Analysis over the forecast period (2020-2024).

Global Beta-Lactam Drugs Market overview:

BIR Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/263483 .

Beta-lactam antibiotics (ß-lactam antibiotics) are the antibiotic agents that contain a beta-lactam ring in their molecular structure. This includes penicillin derivatives (penams), cephalosporins (cephems), monobactams, carbapenems and carbacephems. The Global Beta-Lactam Drugs Market is segmented on the basis of Product Type, Application, End Use Industry and Region.

On the Basis of Product Type segment, the Beta-Lactam Drugs Market is sub segmented into Penicillin, Cephalosporins, Carbapenem and Monobacteria. Based on End Use Industry segment, the Beta-Lactam Drugs Market is sub segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies.

Some of the Beta-Lactam Drugs Market manufacturers involved in the market are GlaxoSmithKline plc, Pfizer Inc., AstraZeneca plc, Merck & Co. Inc., Eli Lilly and Company, Shionogi & Co. Ltd in World, effective mergers are some of the strategies adopted by the Beta-Lactam Drugs Market manufacturers. New product launches and continuous technological innovations are the Beta-Lactam Drugs Market strategies adopted by the major players.

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on "Beta-Lactam Drugs Market Report 2020" @ https://www.businessindustryreports.com/buy-now/263483/single .

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study.

There are several manufacturers of Beta-Lactam Drugss in Europe and North America. In North America, the demand for Beta-Lactam Drugss is primarily driven by the Healthcare sector. Among the countries in Asia Pacific, the demand was substantially high in developing countries such as China and India. These countries have been witnessing rapid increase in its population along with expansion of their overall economies, which has led to increase in disposable income.

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/263483 .

Top Industry News:

GSK and Vir Biotechnology enter collaboration to find coronavirus solutions on 06 April, 2020 -- GlaxoSmithKline plc and Vir Biotechnology, Inc. today announced they have signed a binding agreement to enter into collaboration to research and develop solutions for coronaviruses, including SARS-CoV-2, the virus that causes COVID-19.

The collaboration will use Vir's proprietary monoclonal antibody platform technology to accelerate existing and identify new anti-viral antibodies that could be used as therapeutic or preventative options to help address the current COVID-19 pandemic and future outbreaks. The companies will leverage GSK's expertise in functional genomics and combine their capabilities in CRISPR screening and artificial intelligence to identify anti-coronavirus compounds that target cellular host genes. They will also apply their combined expertise to research SARS-CoV-2 and other coronavirus vaccines.

Dr. Hal Barron, Chief Scientific Officer and President R&D, GSK, said: "Vir's unique antibody platform has precedented success in identifying and developing antibodies as treatments for multiple pathogens, and it is highly complementary with our R&D approach to focus on the science of immunology. I am very excited that the talent and passion of our two companies will come together to develop solutions for multiple diseases, including the very promising antibody candidates targeting COVID-19."

Due to the urgent patient need for COVID-19 solutions, the initial focus of the collaboration will be to accelerate the development of specific antibody candidates identified by the Vir platform, VIR-7831 and VIR-7832 that have demonstrated high affinity for the SARS-CoV-2 spike protein and are highly potent in neutralising SARS-CoV-2 in live virus-cellular assays. Subject to regulatory review, the companies plan to precede directly into a phase 2 clinical trials within the next three to five months.

The collaboration will also utilise Vir's CRISPR screening and machine learning approach to identify cellular targets whose inhibition can prevent viral infection. Vir has identified multiple potential targets against flu and other respiratory pathogens, as well as hepatitis B virus, and will now focus on SARS-CoV-2.

Table of Contents:

1 Beta-Lactam Drugs Product Definition
2 Global Beta-Lactam Drugs Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Beta-Lactam Drugs Shipments
2.2 Global Manufacturer Beta-Lactam Drugs Business Revenue
2.3 Global Beta-Lactam Drugs Market Overview
3 Manufacturer Beta-Lactam Drugs Business Introduction
3.1 GlaxoSmithKline plc Beta-Lactam Drugs Business Introduction
3.1.1 GlaxoSmithKline plc Beta-Lactam Drugs Shipments, Price, Revenue and Gross profit 2020-2024
3.1.2 GlaxoSmithKline plc Beta-Lactam Drugs Business Distribution by Region
3.1.3 GlaxoSmithKline plc Interview Record
3.1.4 GlaxoSmithKline plc Beta-Lactam Drugs Business Profile
3.1.5 GlaxoSmithKline plc Beta-Lactam Drugs Product Specification
3.2 Pfizer, Inc Beta-Lactam Drugs Business Introduction
3.2.1 Pfizer, Inc Beta-Lactam Drugs Shipments, Price, Revenue and Gross profit 2020-2024
3.2.2 Pfizer, Inc Beta-Lactam Drugs Business Distribution by Region
3.2.3 Interview Record
3.2.4 Pfizer, Inc Beta-Lactam Drugs Business Overview
3.2.5 Pfizer, Inc Beta-Lactam Drugs Product Specification
3.3 AstraZeneca plc Beta-Lactam Drugs Business Introduction
3.3.1 AstraZeneca plc Beta-Lactam Drugs Shipments, Price, Revenue and Gross profit 2020-2024
3.3.2 AstraZeneca plc Beta-Lactam Drugs Business Distribution by Region
3.3.3 Interview Record
3.3.4 AstraZeneca plc Beta-Lactam Drugs Business Overview
3.3.5 AstraZeneca plc Beta-Lactam Drugs Product Specification
3.4 Merck & Co., Inc Beta-Lactam Drugs Business Introduction
3.5 Eli Lilly and Company Beta-Lactam Drugs Business Introduction
3.6 Shionogi & Co., Ltd. Beta-Lactam Drugs Business Introduction
................... Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune - India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Beta-Lactam Drugs Market 2020 Report on Study of Annual and Financial Condition of Top Players (GSK, Pfizer, Merck, AstraZeneca) by Growth till 2024 here

News-ID: 2017823 • Views: …

More Releases from Business Industry Reports

Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo International, Nuvo Pharma, Ferndale Pharma, Galen, Jazz Pharma, Paladin Labs, St Renatus, MSK Pharma
Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,…
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size and Leading Players (Lockheed Martin, BAE System, Boeing, General Dynamic, Raytheon) | Forecast to 2025
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market: This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization. According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities…
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growth by Top Key Company’s - J&J, Medtronic, B Braun, Boston Medical, Integra, Stryker, Zimmer, CONMED
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market: This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization. According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,…
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key Players - Apple, Fitbit, Synbiota, THE ODIN, HVMN, Thync Global, Moodmetric
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis: The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast…

All 5 Releases


More Releases for Drugs

Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
Prospect of Global Excipients Market Research Report 2017 with Application inclu …
ResearchMoz added Latest Research Report titled " Global Excipients Market Research Report 2017 " to it's Large Report database. In this report, the global Excipients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD),…
Drugs research: Misuse by shareholders of the drugs industry
A new textbook illustrates the complex and multi-faceted dimensions of evidence building in European drugs research. On one level, the authors have identified practical and philosophical challenges regarding knowledge production including, for example, measurements of the drugs problem; researching the online world; and interpreting on-site drug tests. On another level, the authors have highlighted challenges regarding knowledge production such as the misuse of evidence by knowledge brokers and policymakers.…